ID   PC-6/AMR-OH
AC   CVCL_ZZ79
DR   Wikidata; Q102114743
RX   PubMed=21128075;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=21128075).
CC   Selected for resistance to: ChEBI; CHEBI:156204; Amrubicinol.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
RX   PubMed=21128075; DOI=10.1007/s00280-010-1533-4;
RA   Takakuwa O., Oguri T., Ozasa H., Uemura T., Kasai D., Miyazaki M.,
RA   Maeno K., Sato S.;
RT   "Over-expression of MDR1 in amrubicinol-resistant lung cancer cells.";
RL   Cancer Chemother. Pharmacol. 68:669-676(2011).
//